Physician profile
Wayne A Christenson
NPI 1750324711
$609.56
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $97.47 · 2021: $163.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $163.12 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $84.44 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.91 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $63.72 | 2019 | |
| Janssen Pharmaceuticals, INC | $32.06 | 2019 | |
| Tris Pharma INC | $31.35 | 2019-2020 | |
| Novo Nordisk INC | $28.43 | 2019 | |
| Sunovion Pharmaceuticals INC. | $23.20 | 2019 | |
| Shire North American Group INC | $19.05 | 2019 | |
| Ironshore Pharmaceuticals INC. | $18.81 | 2020 | |
| Allergan, INC. | $18.36 | 2019 | |
| Neos Therapeutics, LP | $15.59 | 2019 | |
| Neurocrine Biosciences, INC. | $15.37 | 2019 | |
| Lundbeck LLC | $14.24 | 2019 | |
| Alkermes, INC. | $11.91 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Christenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.